Thirumalai Chemicals Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Thirumalai Chemicals ha aumentado sus beneficios a una tasa media anual de 8.1%, mientras que los beneficios de la industria de Chemicals han experimentado un crecimiento anual de 16.7%. Los ingresos han ido creciendo a una tasa media de 16.6% al año.
Información clave
8.1%
Tasa de crecimiento de los beneficios
8.1%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 17.7% |
| Tasa de crecimiento de los ingresos | 16.6% |
| Rentabilidad financiera | -2.6% |
| Margen neto | -1.6% |
| Próxima actualización de resultados | 15 May 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Stock Rockets 28% But Many Are Still Ignoring The Company
Apr 13
Here's What's Concerning About Thirumalai Chemicals' (NSE:TIRUMALCHM) Returns On Capital
Aug 30Thirumalai Chemicals (NSE:TIRUMALCHM) Is Paying Out Less In Dividends Than Last Year
Jul 07Capital Allocation Trends At Thirumalai Chemicals (NSE:TIRUMALCHM) Aren't Ideal
Mar 07Thirumalai Chemicals (NSE:TIRUMALCHM) Is Paying Out A Larger Dividend Than Last Year
Jul 16Thirumalai Chemicals' (NSE:TIRUMALCHM) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 02Does Thirumalai Chemicals (NSE:TIRUMALCHM) Have A Healthy Balance Sheet?
Jan 31Investors Shouldn't Overlook The Favourable Returns On Capital At Thirumalai Chemicals (NSE:TIRUMALCHM)
Oct 12Estimating The Intrinsic Value Of Thirumalai Chemicals Limited (NSE:TIRUMALCHM)
Jul 27Thirumalai Chemicals (NSE:TIRUMALCHM) Could Easily Take On More Debt
Jul 02Be Wary Of Thirumalai Chemicals (NSE:TIRUMALCHM) And Its Returns On Capital
Mar 23Trade Alert: Sujatha Sampath At Thirumalai Chemicals Limited (NSE:TIRUMALCHM), Has Just Spent ₹997k Buying A Small Number of Shares
Mar 04Can Mixed Fundamentals Have A Negative Impact on Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Current Share Price Momentum?
Mar 02What Type Of Shareholders Make Up Thirumalai Chemicals Limited's (NSE:TIRUMALCHM) Share Registry?
Feb 15Are Insiders Buying Thirumalai Chemicals Limited (NSE:TIRUMALCHM) Stock?
Jan 25
Did You Participate In Any Of Thirumalai Chemicals' (NSE:TIRUMALCHM) Incredible 429% Return?
Jan 04Here's Why Thirumalai Chemicals (NSE:TIRUMALCHM) Has A Meaningful Debt Burden
Dec 14What Do The Returns On Capital At Thirumalai Chemicals (NSE:TIRUMALCHM) Tell Us?
Nov 23Is Thirumalai Chemicals Limited's (NSE:TIRUMALCHM) Shareholder Ownership Skewed Towards Insiders?
Oct 23Shareholders Of Thirumalai Chemicals (NSE:TIRUMALCHM) Must Be Happy With Their 256% Total Return
Sep 18Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Thirumalai Chemicals. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 23 | 19,875 | -312 | 841 | 0 |
| 30 Sep 23 | 20,039 | 1 | 846 | 0 |
| 30 Jun 23 | 20,339 | 404 | 840 | 0 |
| 31 Mar 23 | 21,322 | 898 | 824 | 0 |
| 31 Dec 22 | 22,841 | 1,927 | 819 | 0 |
| 30 Sep 22 | 23,171 | 2,599 | 831 | 0 |
| 30 Jun 22 | 22,221 | 2,762 | 787 | 0 |
| 31 Mar 22 | 19,982 | 2,812 | 765 | 0 |
| 31 Dec 21 | 18,021 | 2,758 | 714 | 0 |
| 30 Sep 21 | 15,787 | 2,370 | 675 | 0 |
| 30 Jun 21 | 13,694 | 2,029 | 627 | 0 |
| 31 Mar 21 | 10,857 | 1,177 | 554 | 0 |
| 31 Dec 20 | 9,804 | 355 | 498 | 0 |
| 30 Sep 20 | 9,073 | -24 | 471 | 0 |
| 30 Jun 20 | 9,082 | -90 | 481 | 0 |
| 31 Mar 20 | 10,848 | 232 | 522 | 0 |
| 31 Dec 19 | 11,191 | 385 | 496 | 0 |
| 30 Sep 19 | 11,979 | 512 | 486 | 0 |
| 30 Jun 19 | 12,927 | 944 | 473 | 0 |
| 31 Mar 19 | 12,610 | 1,136 | 480 | 0 |
| 31 Dec 18 | 12,786 | 1,355 | 521 | 0 |
| 30 Sep 18 | 12,997 | 1,753 | 547 | 0 |
| 30 Jun 18 | 12,478 | 1,685 | 571 | 0 |
| 31 Mar 18 | 13,120 | 1,704 | 559 | 0 |
| 31 Dec 17 | 12,921 | 1,497 | 546 | 0 |
| 30 Sep 17 | 11,947 | 1,134 | 521 | 0 |
| 30 Jun 17 | 11,450 | 835 | 487 | 0 |
| 31 Mar 17 | 10,285 | 707 | 475 | 0 |
| 31 Dec 16 | 9,652 | 758 | 449 | 0 |
| 30 Sep 16 | 9,214 | 646 | 441 | 0 |
| 30 Jun 16 | 8,972 | 333 | 423 | 0 |
| 31 Mar 16 | 9,442 | 322 | 426 | 0 |
| 31 Dec 15 | 9,254 | 59 | 975 | 12 |
| 30 Sep 15 | 9,796 | -130 | 961 | 12 |
| 30 Jun 15 | 10,313 | 61 | 962 | 12 |
| 31 Mar 15 | 10,723 | -137 | 366 | 0 |
| 31 Dec 14 | 11,462 | -186 | 1,001 | 12 |
| 30 Sep 14 | 11,755 | 15 | 1,003 | 12 |
| 30 Jun 14 | 12,716 | 131 | 1,011 | 12 |
| 31 Mar 14 | 12,762 | 119 | 892 | 12 |
| 31 Dec 13 | 13,255 | 220 | 1,016 | 17 |
| 30 Sep 13 | 13,646 | 264 | 1,003 | 17 |
| 30 Jun 13 | 13,297 | 202 | 991 | 17 |
Ingresos de calidad: TIRUMALCHM actualmente no es rentable.
Margen de beneficios creciente: TIRUMALCHM actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: TIRUMALCHM no es rentable, pero ha reducido pérdidas en los últimos 5 años a un ritmo de 8.1% por año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de TIRUMALCHM en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: TIRUMALCHM no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (-5.2%).
Rentabilidad financiera
Alta ROE: TIRUMALCHM tiene una rentabilidad financiera negativa (-2.57%), ya que actualmente no es rentable.